• Join
  • Login
  • Contact

Search abstracts

Review of economic evidence on the impact of substandard and falsified medicines in low and middle-income countries

  • In: Oral presentation on Tuesday, 12 September 2017, 14:30-17:30
  • At: Seoul (South Korea) (2017)
  • Type: Presentation
  • By: YEMEKE, Tatenda (United States)
  • Co-author(s): Sachiko Ozawa
    Sophia Bessias
    Deson Haynie
    Tatenda Yemeke
    Jim Herrington
  • Abstract:


    Five databases (PubMed, EconLit, Global Health, EMBASE and SCOPUS) were searched for articles containing data on prevalence and/or economic impact of SF medicines in LMICs. Studies that did not seek to quantify the problem or that pertained only to high-income countries were excluded. Data describing setting, medicine, disease target,


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses